- Discovery Alliance Business Reports profitable Growth with Revenues up 54% and a positive operating result of € 9.5 m - Strong Q3 propelled by significant new product Partnering with Roche Hamburg, …
Evotec and Roche agree to develop compound that could slow the progression of Alzheimer's disease
Hamburg, Germany - 5 September 2011: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX) and Roche AG (SIX: RO, ROG; OTCQX: RHHBY) announced today that they have entered into an exclusive worldwide …
Evotec AG – Multi-target collaboration with UCB in neurodegenerative and neurological diseases announced
Hamburg, Germany -7 July 2011: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX) today announced that it has entered into a three year integrated drug discovery collaboration with UCB to identify …
Milestone in an Ion Channel Drug Discovery Collaboration with Ono Pharmaceutical Co., Ltd. achieved
Evotec receives a milestone payment from Ono for the progression of novel ion channel modulators into lead optimization Hamburg, Germany -27 June 2011: Evotec AG (Frankfurt Stock Exchange: EVT, …
Evotec and Roche to jointly develop biomarkers in oncology
An alliance for personalized healthcare in cancer Research and Development Hamburg, Germany and Basel, Switzerland - 24 June 2011: Evotec AG (FSE: EVT, TecDAX) and Roche (SIX: RO, ROG; OTCQX: RHHBY) …
Evotec AG – Medicinal Chemistry Collaboration with Active Biotech
Hamburg, Germany - 6 June 2011: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX) today announced that it has entered into a medicinal chemistry collaboration with Active Biotech AB (NASDAQ OMX: …
Evotec and PsychoGenics Enter into a Strategic Alliance to Provide Integrated CNS Drug Discovery Solutions
Hamburg, Germany - 25 May 2011: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX) today announced that it has entered into a strategic alliance with PsychoGenics Inc. to provide integrated CNS drug …
Evotec reports 54% Q1 revenue growth and significant expansion of drug discovery alliance business
Hamburg, Germany - 12 May 2011: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX) today reported financial results and corporate updates for the first quarter of 2011. · Strong Q1 growth; …
Evotec AG – Full-Year 2010 Results: A good year with a strong start into 2011
Full-Year 2010 Results: A good year with a strong start into 2011 Hamburg, Germany - 24 March 2011: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX) today reported financial results and corporate …
Evotec Establishes Research Collaboration With Harvard University and the Howard Hughes Medical Institute in Diabetes Research
Collaboration Established to Drive Innovation and Develop New Diabetes Therapies Targeting Beta Cell Regeneration Hamburg, Germany, 10 March 2011: Evotec AG (TecDax: EVT) today announced the …